Search

The foundation turned 35, and got a new name.

Gianotti, an Italian particle physicist instrumental in uncovering the Higgs Boson, will replace Rolf-Dieter Heuer, who led CERN through the launch of the Large Hadron Collider

A new £1.25 million arena for flying the next generation of aerial robots will be constructed at Imperial College London, thanks to a generous donation.

Cambridge Epigenetix (CEGX), a UK-based life sciences company, has announced the recent completion of a $5.5M Series A financing round led by New Science Ventures and the appointment of Dr Fedja Bobanovic as CEO. Joining the financing round were founding investors Syncona Partners and Cambridge Enterprise.

Entrepreneur Hermann Hauser gives a positive account of the UK’s Fraunhofer-style innovation centres, but says further substantial investment is needed to exploit the country’s world-leading science base

Incremental innovation won’t do, experts say. At stake is leadership in life sciences, transportation, infrastructure and communications technologies

As a new European Commission sets to work, its energy-chief duo must make sure 2030 targets are met, bring down CO2 emissions and accelerate a single European energy market

Pressure builds on EU member states to agree a budget for 2015 that minimises hurt for researchers

A low-cost text message programme to help young people improve their English language skills won the Science|Business inaugural Global Innovation Award earlier this month. Its founder, Elvis Austins, spells out how he got here and what comes next

Drive-AB has €9.4M to develop new business models to promote industry investment in antibiotics and prevent their inappropriate use

One-time head of IBM Europe and now an MEP, Hans-Olaf Henkel arrives in the EU capital to put his stamp on innovation policy and start a conversation on curtailing what he sees as Commission over-reach

As part of the Clinical Research Infrastructure Initiative, UCL has been awarded £13.5 million for a number of projects to help advance clinical research.

Biologic drugs deliver health and wealth. But it is a long, fraught path from lab to bedside. Science|Business brought together research, business and policymakers to draft a risk-reduction plan for the new Parliament and Commission

Funding to be spent on clinical trials in Africa and assessing safety of experimental vaccine candidates. EMA to speed reviews.

Educators from four countries shared some stories of how methods for nurturing entrepreneurs are changing, at the Science|Business Innovation Connection Summit

Akvolution’s technology combines two different pre-treatment processes in one, cutting the cost of desalination by 25%

Regrets, she has a few, but the real fault lies with politicians that remain tied to an analogue mind-set. The result is a two-speed Europe, says Neelie Kroes as she retires as Digital Commissioner – to be replaced by three men

With some eleventh hour tweaks, Juncker’s team, complete with a new Commissioner for Energy Union, gets over the line